TW200621255A - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- TW200621255A TW200621255A TW094135606A TW94135606A TW200621255A TW 200621255 A TW200621255 A TW 200621255A TW 094135606 A TW094135606 A TW 094135606A TW 94135606 A TW94135606 A TW 94135606A TW 200621255 A TW200621255 A TW 200621255A
- Authority
- TW
- Taiwan
- Prior art keywords
- novel compounds
- neurological
- processes
- preparation
- treatment
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003235 pyrrolidines Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to novel pyrrolidine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0423005A GB0423005D0 (en) | 2004-10-15 | 2004-10-15 | Novel compounds |
| GB0508441A GB0508441D0 (en) | 2004-10-15 | 2005-04-26 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200621255A true TW200621255A (en) | 2006-07-01 |
Family
ID=33462839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094135606A TW200621255A (en) | 2004-10-15 | 2005-10-13 | Novel compounds |
Country Status (3)
| Country | Link |
|---|---|
| GB (2) | GB0423005D0 (en) |
| PE (1) | PE20061182A1 (en) |
| TW (1) | TW200621255A (en) |
-
2004
- 2004-10-15 GB GB0423005A patent/GB0423005D0/en not_active Ceased
-
2005
- 2005-04-26 GB GB0508441A patent/GB0508441D0/en not_active Ceased
- 2005-10-13 PE PE2005001211A patent/PE20061182A1/en not_active Application Discontinuation
- 2005-10-13 TW TW094135606A patent/TW200621255A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0508441D0 (en) | 2005-06-01 |
| PE20061182A1 (en) | 2006-10-22 |
| GB0423005D0 (en) | 2004-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200500344A (en) | Novel compounds | |
| TW200503713A (en) | Novel compounds | |
| TW200503710A (en) | Novel compounds | |
| GB0329214D0 (en) | Novel compounds | |
| TW200531689A (en) | Therapeutic agents | |
| TW200621716A (en) | Novel compounds | |
| TW200504034A (en) | Therapeutic agents | |
| TW200514781A (en) | Novel compounds | |
| TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
| TW200635903A (en) | Therapeutic agents | |
| GB0111186D0 (en) | Novel compounds | |
| GB0420831D0 (en) | Novel compounds | |
| IL188184A0 (en) | Pyrazolo [3,4-d] azepine derivatives as histamine h3 antagonists | |
| IL185869A0 (en) | Fused thiazole derivatives having affinity for the histamine h3 receptor | |
| TW200611701A (en) | Novel compounds | |
| TW200633986A (en) | Therapeutic agents | |
| IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| GB0320320D0 (en) | Novel compounds | |
| MX2007006754A (en) | Indenyl derivatives and use thereof for the treatment of neurological disorders. | |
| PT1853232E (en) | Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them | |
| WO2005097778A8 (en) | Tetrahydrobenzazepines as histamine h3 receptor ligands | |
| TW200726763A (en) | Novel compound | |
| TW200734324A (en) | Therapeutic agents | |
| TW200621255A (en) | Novel compounds | |
| WO2004056821A3 (en) | Quinolizidine derivatives |